资源类型:
期刊
WOS体系:
Article
Pubmed体系:
Journal Article
收录情况:
◇ SCIE
文章类型:
论著
机构:
[1]Research Center, China Resources Sanjiu Medical & Pharmaceutical Co. Ltd., Shenzhen 518110, China.
[2]Center Lab of Longhua Branch, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University), Shenzhen 518020, Guangdong, China.
深圳市龙华区人民医院
深圳市人民医院
深圳医学信息中心
[3]College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
ISSN:
1389-2010
摘要:
Baicalin, a flavonoid glycoside compound present in Scutellaria baicalensis, has shown a wide spectrum of biological activities, but its liposolubility, water-solubility and mucosal permeability are all very poor, which lead to the low concentration in brain and poor bioavailability by oral or intravenous injective administration.The primary objective of this study was to formulate the Scutellaria baicalensis extract (SBE) with phospholipid to yield Scutellaria baicalensis extract-phospholipid complex (SBEPC) and to screen the appropriate administration and dose of SBEPC through the pharmacodynamics experiment.The optimal preparation process of SBEPC was obtained through single-factor test and central composite design-response surface methodology (CCD-RSM), and was characterized with various analytical techniques including SEM, FT-IR and NMR. The storage conditions of SBEPC were established through stability study and the middle cerebral artery occlusion (MCAO) rat model was investigated through conducting pharmacodynamic studies to screen the appropriate administration and dose of SBEPC as well as to verify the neuroprotective effect of SBEPC on cerebral ischemia-reperfusion injury.The optimized preparation conditions of SBEPC were summarized as follows: the ratio of phospholipids to drug was 2:1, the drug concentration was 3.5 mg/ml, the reaction temperature was 50 °C, the entrapment efficiency was over 93.00%. Stability studies have demonstrated that SBEPC should be stored under 40 °C in a dry and ventilated place away from light and below 37% humidity. Furthermore, pharmacodynamic studies have found that, compared with SBE, SBEPC could introduce drugs into the brain and better exert the neuroprotective effect on MCAO rats, and the optimal administration and dose concentration of SBEPC were nasal administration and 40 mg/ml, respectively.These findings demonstrate that SBEPC was successfully prepared by CCD-RSM. SBEPC can enhance the ability of drugs entering the brain and improve the bioavailability of drugs in brain, and can effectively exert the neuroprotective effect on cerebral ischemia-reperfusion injury as compared with SBE.Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
WOS:
WOS:000763325100008
PubmedID:
34376131
中科院(CAS)分区:
出版当年[2021]版:
大类
|
4 区
医学
小类
|
4 区
生化与分子生物学
4 区
药学
最新[2025]版:
大类
|
4 区
医学
小类
|
4 区
生化与分子生物学
4 区
药学
JCR分区:
出版当年[2020]版:
Q3
PHARMACOLOGY & PHARMACY
Q3
BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版:
Q3
PHARMACOLOGY & PHARMACY
Q4
BIOCHEMISTRY & MOLECULAR BIOLOGY
影响因子:
2.2
最新[2023版]
2.4
最新五年平均
2.837
出版当年[2020版]
2.626
出版当年五年平均
2.097
出版前一年[2019版]
2.829
出版后一年[2021版]
第一作者:
Chen Shibin
第一作者机构:
[1]Research Center, China Resources Sanjiu Medical & Pharmaceutical Co. Ltd., Shenzhen 518110, China.
推荐引用方式(GB/T 7714):
Chen Shibin,Xie Qiujie,Yang Ming,et al.Scutellaria baicalensis Extract-Phospholipid Complex: Preparation and Initial Pharmacodynamics Research in Rats.[J].CURRENT PHARMACEUTICAL BIOTECHNOLOGY.2022,23(6):847-860.doi:10.2174/1389201022666210729142257.
APA:
Chen Shibin,Xie Qiujie,Yang Ming,Shi Yajun,Shi Junhui&Zeng Xiaobin.(2022).Scutellaria baicalensis Extract-Phospholipid Complex: Preparation and Initial Pharmacodynamics Research in Rats..CURRENT PHARMACEUTICAL BIOTECHNOLOGY,23,(6)
MLA:
Chen Shibin,et al."Scutellaria baicalensis Extract-Phospholipid Complex: Preparation and Initial Pharmacodynamics Research in Rats.".CURRENT PHARMACEUTICAL BIOTECHNOLOGY 23..6(2022):847-860